Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis
- Conditions
- CirrhosisPortal Hypertension
- Interventions
- Dietary Supplement: DarkChocolateDietary Supplement: WhiteChocolate
- Registration Number
- NCT01408966
- Lead Sponsor
- Hospital Clinic of Barcelona
- Brief Summary
This study was aimed at testing the hypothesis that supplementing a meal with dark chocolate, which holds potent antioxidant properties, might attenuate the postprandial increase in the hepatic venous pressure gradient (HVPG, clinical equivalent of portal pressure) in patients with cirrhosis
- Detailed Description
Previous studies showed that the intrahepatic circulation in cirrhosis is not able to adapt to sudden increases in blood flow, such as that occurring after a meal, due to endothelial dysfunction. This leads to a brisk increase in portal pressure (estimated by the HVPG). This method is therefore useful to assess the efficacy of compounds potentially ameliorating intrahepatic endothelial dysfunction. Dark chocolate, which contains a high proportion of cocoa flavonoids such as cathechin and epicatechin- powerful antioxidants, increases NO availability in the systemic circulation and improves systemic endothelial function. We hypothesised that the antioxidant properties of dark chocolate could be beneficial in patients with cirrhosis, since they might improve intrahepatic endothelial dysfunction. Consequently, the aim of this study was to evaluate whether a dark chocolate-containing test meal may attenuate the post-prandial increase in HVPG in patients with cirrhosis and portal hypertension.
HVPG was measured at baseline and 30 minutes after the administration of a test meal supplemented by either dark or white chocolate. Portal vein blood flow and hepatic artery blood flow were measured by Doppler ultrasound. Catechins and NOx were determined for both timepoints.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
- age over 18 years
- diagnosis of cirrhosis (proven by biopsy or clinical, laboratory and imaging procedures)
- presence of esophageal varices of any grade
- HVPG ≥ 10 mmHg during the hemodynamic study
- food allergy to chocolate
- ongoing treatment with ascorbic acid and/or other antioxidants
- diffuse or multinodular hepatocellular carcinoma
- pregnancy
- advanced hepatic failure (defined as prothrombin ratio < 40% and bilirubin > 5 mg/dL)
- renal failure (defined by a serum creatinine level > 1.5 mg/dL)
- portal vein thrombosis
- cardiac or respiratory failure
- previous surgical or transjugular intrahepatic portosystemic shunt
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description DarkChocolate DarkChocolate 11 patients were randomized to receiving dark chocolate 0.55 g/kg of body weight (Lindt Excellence 85% Cocoa, Lindt \& Sprüngli España) together with the test meal White chocolate supplementation WhiteChocolate 11 patients received 0.63 g/kg white chocolate (Lindt Excellence Natural Vanilla, Lindt \& Sprüngli España) in an iso-caloric and iso-volumetric proportion adjusted to body weight.
- Primary Outcome Measures
Name Time Method Postprandial change in HVPG (% change and absolute change in mmHg) 30 minutes
- Secondary Outcome Measures
Name Time Method Post-prandial change in portal vein blood flow by US-Doppler 30 minutes Post-prandial change in nitric oxide metabolites 30 minutes Post-prandial changes in catechin and epicatechin 30 minutes Post-prandial changes in mean arterial pressure 30 minutes
Trial Locations
- Locations (1)
Hepatic Hemodynamic Laboratory. Liver Unit. Hospital Clinic.
🇪🇸Barcelona, Spain